Evidence map›Paper›PMID 41385056›Full record

ArticleThe international journal of cardiovascular imaging2026

The performance of free-breathing multiparametric SAturation-recovery single-SHot acquisition T1 and T2 mapping in cardiac allograft rejection.

Nikolaos Miaris, Husein Rajabali, Nicholas M Quaife, Fernando Riesgo Gil, Owais Dar, Andrew Morley-Smith, Jan Lukas Robertus, Muhammad Usman, Antonis Pantazis, Rajasi Banerjee and 6 more

Abstract read
In one paragraph

Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nikolaos MiarisRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-3917-0918
Husein RajabaliRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Nicholas M QuaifeRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0003-2755-2086
Fernando Riesgo GilRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-3094-0867
Owais DarRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-7557-8769
Andrew Morley-SmithRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0003-3005-6382
Jan Lukas RobertusRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Muhammad UsmanRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Antonis PantazisRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Rajasi BanerjeeRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Barbara SegulinRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0009-0002-2016-9519
Thomas LuescherRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-5259-538X
Chiara Bucciarelli-DucciRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-2515-0852
Kelvin ChowCardiovascular MR R&D, Siemens Healthcare Ltd., Calgary, AB, Canada.
Peter KellmanNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-9875-6070
Joyce WongRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK. joyce.wong4@nhs.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular magnetic resonance (CMR) has been studied as an alternative to endomyocardial biopsy (EMB) in orthotopic heart transplant recipients (OHTRs), particularly through breath-hold myocardial T1 and T2 mapping sequences. We aimed to assess the diagnostic performance of the novel free-breathing multiparametric saturation-recovery single-shot acquisition (mSASHA) mapping technique to identify acute cardiac allograft rejection (ACAR) non-invasively against EMB. This retrospective study included n = 21 consecutive OHTRs with suspected ACAR who underwent both a 1.5T CMR scan with mSASHA mapping and an EMB within 5.4 (1.2-14.8) days, and n = 20 healthy controls who underwent CMR with mSASHA mapping. Conventional breath-holding T2-prepared balanced steady-state free precession (T2p-bSSFP) T2 mapping was also acquired. CAR was EMB defined as histological rejection (HR) (acute cellular rejection of ≥ 1 R or acute antibody-mediated rejection of ≥ 1). Overall, n = 21 OHTRs (9 females) with a mean age of 43.2 ± 16.2 years and a median time of 5.4 (1.2-14.8) years since transplantation were included in the study, alongside n = 20 healthy controls. HR was present in n = 9 patients. The HR group showed significantly higher septal mSASHA T2 values compared to the non-HR (n = 12) group (53 ± 6 ms vs. 47 ± 4 ms, p = 0.014). Receiver operator characteristics analysis showed an area under the curve of 0.79 (95% confidence interval 0.59-0.98, p = 0.028) and an optimal cut-off value of 50 ms (sensitivity of 67%, specificity of 75%) for identifying patients with HR using septal mSASHA T2 values. There was at least a moderate correlation of septal and global mSASHA T1 and T2 values (n = 21) with MOLLI T1 (n = 17) and T2p-bSSFP T2 (n = 18) values (r > 0.6, p ≤ 0.003). OHTR patients without HR showed higher septal (T1: 1256 ± 42 ms vs. 1201 ± 46 ms, p = 0.002; T2: 47 ± 4 ms vs. 43 ± 2 ms, p = 0.003) and global mSASHA (T1: 1250 ± 58 ms vs. 1201 ± 45 ms, p = 0.013; T2: 48 ± 5 ms vs. 43 ± 2 ms, p = 0.009) values compared to normal controls (n = 20). In the control group, native mSASHA T1 and T2 values were higher in females (n = 9) than in males. Free-breathing mSASHA T2 mapping may be useful in identifying histological changes associated with ACAR, overcoming the challenges of breath holding and with good diagnostic performance.

Indexed as

Graft RejectionHeart TransplantationMagnetic Resonance ImagingMagnetic Resonance Imaging, CineMyocardiumRespirationAdultAllograftsBiopsyCase-Control StudiesFemaleHumansMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsCardiac allograft rejectionCardiovascular magnetic resonanceHeart transplantmSASHAParametric mapping

Identifiers

PMID41385056
PMCPMC12847199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.